Down to the state of journalism again, but not one mention of the fact that MNTA (An American company) has raised the bar in the quality of generic that is possible to be created as MNTA has created a precise copy of the name brand drug, and insured its quality to at least the same standard as the name brand drug, whereas Teva (an Israeli company) is trying to push onto the market a generic knock-off lovenox that is not really the same, and which could endanger the health and welfare of patients.
The way the article reads you'd think there was no difference between the applications.
Tinker
Market Data 
Markets 
AI
